b Tested in sodium chloride 0.9%.
c Test performed using the formulation WITHOUT edetate disodium.
d Tested in both dextrose 5% and sodium chloride 0.9%.
e Tested in dextrose 5% in Ringer’s injection, dextrose 5% in Ringer’s injection, lactated, dextrose 5%, Ringer’s injection, lactated, and sodium chloride 0.9%.
f Tested in Ringer’s injection, lactated.
g Extemporaneously prepared product.
h Lyophilized formulation tested.
i Refer to Appendix for the composition of parenteral nutrition solutions. TNA indicates a 3-in-1 admixture, and TPN indicates a 2-in-1 admixture.
j Tested in dextrose 5% in sodium chloride 0.225%.
k Piperacillin component. Piperacillin in an 8:1 fixed-ratio concentration with tazobactam.
l Trimethoprim component. Trimethoprim in a 1:5 fixed-ratio concentration with sulfamethoxazole.
m Ceftolozane component. Ceftolozane in a 2:1 fixed-ratio concentration with tazobactam.
n Meropenem component. Meropenem in a 1:1 fixed-ratio concentration with vaborbactam.
o Ceftazidime component. Ceftazidime in a 4:1 fixed-ratio concentration with avibactam.
p Tested in dextrose 5%, sodium chloride 0.9%, and Ringer’s injection, lactated.
q Test performed using the formulation WITH edetate disodium.
r Imipenem component. Imipenem in a 2:2:1 fixed-ratio concentration with cilastatin and relebactam.
s Sulbactam component. Sulbactam in a 1:1 fixed-ratio concentration with durlobactam.